CAPROLACTAM CHEMICALS LTD.

Caprolactam Chemicals Ltd announced the resignation of its internal auditors, M/s. Shrey Pandey & Associates, effective September 10th, 2026. The resignation was due to pre-occupation with other professional commitments and does not raise concerns regarding the company's management. The Audit Committee and Board will consider the appointment of a new internal auditor in due course. Concurrently, Parth Patel D & Associates has been appointed as the new internal auditor, effective September 10th, 2026, for the Financial Year 2026-27. They are a member of The Institute of Chartered Accountant of India and have no relationship with the company's directors.

Caprolactam Chemicals Ltd has submitted its Annual Report for FY 2025-26, along with the Notice of the 37th Annual General Meeting (AGM) scheduled for September 28, 2026. The AGM will be conducted via Video Conference/Other Audio-Visual Means. Key agenda items include the adoption of the financial statements, reappointment of a director retiring by rotation, and the appointment of Raman S. Shah & Co. as statutory auditors for a five-year term. The company also detailed the e-voting process, with the cut-off date for remote e-voting set as September 21, 2026, and the remote e-voting period from September 24 to September 27, 2026. The full report is available on the company's website.

Caprolactam Chemicals Ltd has announced its 37th Annual General Meeting (AGM) will be held on September 28, 2026, at 10:30 a.m. IST. The meeting will be conducted through Video Conference/Other Audio-Visual Means. Key agenda items include the adoption of the Annual Audited Financial Statements for FY 2025-26, the reappointment of Ms. Zaver Shankarlal Bhanushali as a director retiring by rotation, and the appointment of Raman s. Shah & co as statutory auditors for a term of five consecutive years.

Caprolactam Chemicals Limited's Board of Directors, following a recommendation from the Audit Committee, has proposed the appointment of M/s. Raman S. Shah & Co. as the new Statutory Auditors. This appointment is subject to shareholder approval at the upcoming Annual General Meeting (AGM). The board also approved other agenda items, including the appointment of a scrutinizer for e-voting, the Director's Report for FY26, the draft notice for the 37th AGM, and the appointment of Purva Sharegistry (India) Pvt. Ltd. for e-voting services. The record date for voting eligibility was set as September 21, 2026, with the e-voting period from September 24 to September 27, 2026.

Caprolactam Chemicals Limited announced the outcome of its Board Meeting held on August 13, 2026. The Board approved the Unaudited Standalone Financial Results for the quarter ended June 30, 2026. These results were recommended by the Audit Committee and approved by the Board. The meeting commenced at 12:00 p.m. and concluded at 1:00 p.m. The company has submitted the financial results along with the Limited Review Report from its statutory auditors.

Caprolactam Chemicals Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda item is to consider, approve, and take on record the Unaudited Financial Results for the quarter ended June 30, 2026. Additionally, the company has closed its trading window from July 1, 2026, which will remain shut for 48 hours post the announcement of the financial results, in compliance with SEBI regulations. The company will also upload this intimation on its website.

Caprolactam Chemicals Ltd has announced the closure of its trading window for designated persons. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of financial results for the quarter ended June 30, 2026. The company has informed its designated persons not to trade in its securities during this period, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The date for the board meeting to declare these financial results will be communicated separately.

Caprolactam Chemicals Ltd's board approved the audited financial results for the quarter and financial year ended March 31, 2026. The company's revenue from operations for FY26 stood at ₹1,055.75 lakhs, compared to ₹673.96 lakhs in FY25. Net profit after tax for FY26 was ₹176.12 lakhs, a significant improvement from a loss of ₹(70.87) lakhs in the previous year. M/s. Shrey Pandey & Associates were appointed as the Internal Auditor for FY 2026-27.

Caprolactam Chemicals Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The trading window has been closed from April 1, 2026, and will remain closed until 48 hours after the public announcement of the results. The information is available on the company's website.

Caprolactam Chemicals Ltd is not required to comply with Regulation 23(9) of the SEBI (LODR) Regulations, 2015, concerning Related Party Transaction disclosures. As of March 31, 2025, the company's paid-up equity share capital is ₹4,60,00,000 and its net worth is ₹4,95,89,569, falling below the threshold of ₹10 crore paid-up equity share capital and ₹25 crore net worth as specified in Regulation 15(2) of SEBI (LODR) Regulations, 2015.